Talanta

Highly sensitive electrochemical detection of ciprofloxacin using combined CRISPR/Cas12a and exonuclease III amplification

Updated

Abstract

A limit of detection as low as 0.022 ng mL for ciprofloxacin is achieved using an ultrasensitive electrochemical biosensor.

  • The biosensor utilizes CRISPR/Cas12a and exonuclease III for enhanced detection capabilities.
  • Ciprofloxacin presence triggers a change in DNA probes, activating a cascade amplification process.
  • The amplification leads to a significant increase in DNA fragments, which further activates CRISPR/Cas12a's cleavage activity.
  • This process results in a notable change in the electrochemical signal, facilitating the detection of ciprofloxacin.
  • The biosensor demonstrates high precision, specificity, and stability for detecting ciprofloxacin in real food samples.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free